WASHINGTON, US: In June, Hiossen, Osstem Implant’s US subsidiary, received the esteemed President’s “E” Award, underscoring the company’s commitment to providing high-quality dental implant solutions globally while nurturing its domestic and international growth. By expanding its operations, fostering strong partnerships and prioritising innovation, Hiossen said that it is well positioned to continue its trajectory as a trusted leader in the industry.
The President’s “E” Award represents the highest accolade bestowed on US companies that have made significant contributions to expanding American exports and capturing international market share. Presented annually by the US Department of Commerce, this prestigious recognition acknowledges Hiossen’s commitment to advancing international trade, fostering economic growth, and promoting American products and services on a global scale.
While Hiossen has long been recognised for its exceptional performance in the US, the company has also been making remarkable strides in global exports. By focusing on providing superior dental implant solutions to dentists and patients across the world, Hiossen has solidified its position as a reliable manufacturer.
Commenting on the award, Hiossen CEO Kyung R. Lee said, “We are truly honoured to be one of just 11 companies receiving the esteemed President’s ‘E’ Award, which not only recognises our remarkable achievements in expanding our own export operations but also celebrates Hiossen’s significant contribution in increasing US exports. This recognition is a testament to the hard work and dedication of our entire team, as well as the unwavering support and trust of our valued partners and customers.”
Internationally, Hiossen has achieved significant growth and innovation, driven by its dedicated workforce and commitment to excellence. The company has made substantial investments in research and development, leading to groundbreaking advancements in dental implant technology. Through a comprehensive and dynamic product portfolio, Hiossen continues to raise the bar in implantology, improving patient outcomes and empowering dental professionals with trail-blazing solutions.
“We believe that fostering international growth is essential to achieving our vision of transforming smiles and improving lives,” added Lee. “By empowering our employees, investing in their professional development and cultivating a culture of innovation, we are better equipped to meet the evolving needs of the dental industry and exceed the expectations of our valued customers.”
Tags:
SEOUL, South Korea: The Osstem Biotechnology R & D Center was announced as an organisation affiliated to the recently established Tissue Regeneration ...
SEOUL, South Korea: On a yearly basis, Osstem Implant’s subsidiaries organise the Osstem Meetings, which are country-specific events, in their respective ...
SEOUL, South Korea: Osstem Implant is the first South Korean dental implant company to exceed KRW 1 trillion in revenue, according to its 16 March 2023 ...
SEOUL, Korea: After the global success of Osstem Implant’s K3 dental chair unit, more than 40,000 units having been sold in 72 countries, Osstem has ...
ISTANBUL, Turkey: Osstem Implant’s subsidiary in Turkey has announced that, in collaboration with the Turkish Dental Association, it has provided ...
COLOGNE, Germany: Osstem Implant, a leading company in the global dental market, has announced that it will be showcasing its various dental products at the...
Dr. Marco Tallarico DDS, M.Sc. in Oral Surgery
To post a reply please login or register